Free Trial

Lyra Therapeutics (LYRA) SEC Filings & 10K Form

Lyra Therapeutics logo
$0.09 0.00 (-0.22%)
As of 04:00 PM Eastern

Recent Lyra Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2025
2:44 PM
Lyra Therapeutics (Subject)
Palasis Maria (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2025
7:59 AM
Lyra Therapeutics (Filer)
Form DEF 14A
04/04/2025
8:01 AM
Lyra Therapeutics (Filer)
Form DEFA14A
03/25/2025
3:30 PM
Lyra Therapeutics (Filer)
Form PRE 14A
02/14/2025
5:22 PM
CITADEL ADVISORS LLC (Filed by)
Lyra Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
8:02 PM
Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
12/13/2024
4:06 PM
Lyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:39 PM
Lyra Therapeutics (Issuer)
Waksal Harlan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:54 PM
Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:48 PM
Lyra Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM
Lyra Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:49 PM
Lyra Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:53 PM
Lyra Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
08/15/2024
5:31 PM
Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
07/23/2024
3:05 PM
Lyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:15 PM
Lyra Therapeutics (Filer)
Form 8-K/A
05/21/2024
8:15 AM
Lyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
3:15 PM
Lyra Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
3:36 PM
Lyra Therapeutics (Filer)
Form DEFA14A
04/19/2024
3:17 PM
Lyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
3:20 PM
Lyra Therapeutics (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:LYRA) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners